Study to Evaluate the Pharmacokinetic (PK) Interactions Between GSK3640254 and Dolutegravir (DTG)
Clinical trial NCT03816696 · COMPLETED
Trial details
- NCT number
- NCT03816696
- Sponsor
- ViiV Healthcare
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-23
- Primary completion
- 2019-03-30
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.